Evidence map›Paper›PMID 32257079›Full record

ArticleJournal of public health in Africa2019

Mentored postdoctoral training in Zimbabwe: A report on a successful collaborative effort.

Danai T Zhou, Charles C Maponga, Munyaradzi Madhombiro, Admire Dube, Runyararo Mano, Albert Nyamhunga, Ian Machingura, Justen Manasa, James Hakim, Z Mike Chirenje and 6 more

Abstract read
In one paragraph

Article in Journal of public health in Africa, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Strategies for Implementation Research to Investigate the Negative Pharmacokinetic Interaction Between Efavirenz and Dolutegravir.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Danai T ZhouDepartment of Medical Laboratory Sciences, University of Zimbabwe, Harare, Zimbabwe.
Charles C MapongaSchool of Pharmacy, University of Zimbabwe, Harare, Zimbabwe.
Munyaradzi MadhombiroDepartment of Psychiatry, University of Zimbabwe, Harare, Zimbabwe.
Admire DubeSchool of Pharmacy, University of the Western Cape, Bellville, South Africa.
Runyararo ManoDepartment of Pediatrics, University of Zimbabwe, Harare, Zimbabwe.
Albert NyamhungaDepartment of Radiology, University of Zimbabwe, Harare, Zimbabwe.
Ian MachinguraDepartment of Medical Laboratory Sciences, University of Zimbabwe, Harare, Zimbabwe.
Justen ManasaDepartment of Medical Microbiology, University of Zimbabwe, Harare, Zimbabwe.
James HakimDepartment of Medicine, University of Zimbabwe, Harare, Zimbabwe.
Z Mike ChirenjeDepartment of Obstetrics and Gynecology, University of Zimbabwe, Harare, Zimbabwe.
Tinashe MudzvitiSchool of Pharmacy, University of Zimbabwe, Harare, Zimbabwe.
Charles NhachiDepartment of Clinical Pharmacology, University of Zimbabwe, Harare, Zimbabwe.
Qing MaCenter for Integrated Global Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA.
Robin DiFrancescoCenter for Integrated Global Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA.
Rangarirai MasanganiseDepartment of Ophthalmology, University of Zimbabwe, Harare, Zimbabwe.
Gene D MorseCenter for Integrated Global Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA.

Funding

HIV Research Training ProgramD43TW010313 · FIC · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Charles Enos Chiedza Maponga, Gene D. Morse · 2016 to 2026
$3.2M
Antiretroviral Pharmacology Training in Resource Poor CountriesD43TW007991 · FIC · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MORSE, GENE D. · 2009 to 2015
$1.6M
Development of Nanomedicines for Tuberculosis TreatmentK43TW010371 · FIC · UNIVERSITY OF THE WESTERN CAPE · PI DUBE, ADMIRE · 2017 to 2021
$370k
FIC NIH HHS D43 TW007991FIC NIH HHS D43 TW010313FIC NIH HHS K43 TW010371
6 · The paper itself

Abstract

Low-and-middle-income countries (LMICs) have high disease burdens, necessitating increased research. However, LMIC research output constitutes only 2% of global total. To increase output, researchers must be capacitated. The University of Zimbabwe (UZ) and the University at Buffalo (UB), developed and implemented the AIDS International Research Training Program (AITRP), in 2008, that focused on graduate scholars. The subsequent HIV Research Training Program (HRTP), begun in 2016, and piloted post-doctoral training to enhance research productivity at UZ. This report discusses the collaboration. As of 2016, prospective candidates applied by submitting letters of intent, research proposals, curriculum vitae and biographical sketches. The scholars research training included hypothesis and project development, completion of grant applications, research project budgets, research presentations to diverse audiences and the application of advanced statistics to research data. The first cohort of five postdoctoral scholars were trained at UZ and UB, between 2016 and 2019. Through the formalized postdoctoral training approach, scholars identified areas of focus. In 2017, one of the scholars obtained a National Institutes of Health (NIH) Emerging Global Leader Award and is now a highly-rated researcher based in South Africa. A second scholar made NIH D43 and K43 grant applications, while the remaining three are academicians and early researchers at UZ. Although research output in Africa and many LMICs is low, it can be built through cooperation similar to the UZ-UB HRTP. This manuscript reports on an effort aimed at building individual and institutional research capacity in Zimbabwe. This can serve as a model for building other similar training programs.

Indexed as

formalizedHRTPLMICpostdoctoralZimbabwe

Identifiers

PMID32257079
PMCPMC7118437

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.